Jafron Biomedical Co Ltd operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jafron Biomedical Co Ltd with three other
companies in this sector in China:
Guangzhou Well Lead Medical Equipment Co Ltd
sales of 745.83 million Chinese Renmimbi [US$106.38 million]
of which 99%
was Medical Equipment),
Beijing Bohui Innovation Biotechnology Co Ltd
(622.09 million Chinese Renmimbi [US$88.73 million]
of which 53%
was Blood Product), and
Shanghai Kinetic Medical Co Ltd
(930.91 million Chinese Renmimbi [US$132.78 million]
of which 68%
was Medical Instrument Manufacturing).
During the year ended December of 2018, sales at
Jafron Biomedical Co Ltd were 1.02 billion Chinese Renmimbi (US$144.98 million).
increase of 41.5%
versus 2017, when the company's sales were 718.49 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jafron Biomedical Co Ltd
(and since 2013, sales have increased a total of 235%).
Sales of Medical Device Manufacturing saw an increase
41.6% in 2018, from
715.69 million Chinese Renmimbi to 1.01 billion Chinese Renmimbi.